Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Japanese Journal of Clinical Oncology|March 16, 2013
Takeda's Oncology Discovery StrategyBrian DeSchuytner, Kyle Kuvalanka, Barbara Hibner, et al.
Toxicology and Applied Pharmacology|July 15, 2024
Can we do better with Mylotarg? Model-based assessment of opportunities to improve therapeutic indexMadison Stoddard, Lin Yuan, Jodi Cooper, et al.
Biochemical Pharmacology|October 19, 2006
Tezacitabine enhances the DNA-directed effects of fluoropyrimidines in human colon cancer cells and tumor xenograftsPietro Taverna, Katherine Rendahl, Dragana Jekic-McMullen, et al.
Molecular Cancer Therapeutics|March 26, 2017
MET Tyrosine Kinase Inhibition Enhances the Antitumor Efficacy of an HGF AntibodyPamela J Farrell, Jennifer Matuszkiewicz, Deepika Balakrishna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
CHIR-124, a novel potent inhibitor of Chk1, potentiates the cytotoxicity of topoisomerase I poisons in vitro and in vivoArchie N Tse, Katherine G Rendahl, Tahir Sheikh, et al.
Bioorganic & Medicinal Chemistry Letters|January 27, 2004
Omega-carboxypyridyl substituted ureas as Raf kinase inhibitors: SAR of the amide substituentUday R Khire, Donald Bankston, James Barbosa, et al.
Pageof 1